TXT In plain English
Company description
IPSEN BIOPHARM LIMITED is a UK company whose Companies House status is “Active” and whose registered company type is “Private Limited Company”. Incorporated on 23 July 1982; registered for 44 years; registered office reported in WREXHAM. Its primary declared activity is 21100 · Manufacture of basic pharmaceutical products.
This BritDB profile also contains linked public records: 1 PSC record, 30 trade marks. This description is assembled from public data, is not a reliability assessment, and should be checked against the cited sources before a legally significant decision.
Web facts are never added from a name match alone. Internet enrichment requires the exact Companies House ID in Wikidata, and ambiguous results are excluded.
01 Company overview
Identity and registration
- Official name
- IPSEN BIOPHARM LIMITED
- Company number
- 01653765
- Company type
- Private Limited Company
- Status
- Active
- Country of origin
- United Kingdom
- Dissolution date
- Not supplied
- Accounts category
- FULL
- Mortgage charges
- 5 total · 0 outstanding · 5 satisfied
- Limited partnership members
- 0 general · 0 limited
A registered office is not necessarily a trading location. The address is reproduced from the Companies House bulk record and should be interpreted in that legal context.
02 Filing dates
Accounts and statements
Last accounts made up to
31 December 2024Next accounts due
30 September 2026Last statement made up to
3 October 2025Next statement due
17 October 2026BritDB does not infer overdue status when the source does not state it.
03 Workforce reporting
Gender pay gap
- Median bonus gap
- 2.6%
- Mean bonus gap
- 14.2%
- Women receiving bonus
- 79.0%
- Men receiving bonus
- 81.4%
- Women in top quartile
- 51.3%
- Women in upper middle quartile
- 44.4%
- Women in lower middle quartile
- 46.5%
- Women in lower quartile
- 54.0%
Earlier reporting years (8)
- 500 to 9992.6% median hourly gap
- 500 to 9994.4% median hourly gap
- 500 to 9997.0% median hourly gap
- 500 to 9996.8% median hourly gap
- 500 to 9996.0% median hourly gap
- 500 to 9995.4% median hourly gap
- 500 to 9992.7% median hourly gap
- 250 to 4999.1% median hourly gap
Positive gaps mean men were paid more; negative gaps mean women were paid more. These figures are employer-reported and describe the workforce distribution, not equal pay for the same job. The company link uses the exact Companies House number supplied by the service.
04 Supplier payments
Payment practices and performance
- Reporting period
- 1 January 2026 – 30 June 2026
- Filed
- 28 July 2026
- Shortest standard term
- 30 days
- Longest standard term
- 60 days
- E-invoicing offered
- No
- Supply-chain finance
- Not offered
- Payment codes
- No
- Construction retentions
- Reported as used
Complete reported payment fields
- Policy regime
- Regime-3
- Financial period started
- 1 January 2026
- Qualifying contracts
- Yes
- Payments made
- Yes
- Invoice value paid within 30 days
- £59,088,238
- Invoice value paid in 31–60 days
- £176,529,559
- Invoice value paid after 60 days
- £43,057,471
- Invoice value paid outside agreed terms
- £75,992,275
- Invoices paid in 31–60 days
- 32.0%
- Invoices unpaid due to dispute
- 0.0%
- Maximum contractual payment period
- 60 days
- Supplier-list charging policy
- No
- Supplier-list charges made
- No
Payment terms changed
Standard terms have changed from 30 days to 60 days but only for newly created vendors. This has no impact on historical vendors.
Retention release
The retention will be kept for a period of time, and can be released all at once or some contracts release part of it after X amount of time and the rest after another period of time. Each retention release will be approved by the project Manager and Project Director prior to payment being agreed.
Retention release stages
The retention will be kept for a period of time, and can be released all at once or some contracts release part of it after X amount of time and the rest after another period of time. Each retention release will be approved by the project Manager and Project Director prior to payment being agreed.
- Retention in all contracts
- Yes
- Retention in standard terms
- No
- Retention threshold
- Not supplied
- Standard retention rate
- Not supplied
- Retention compared with client
- 0.0%
- Retention compared with payments
- 0.0%
Reported terms and dispute process
- Standard payment terms
Standard payment terms: 30 days from the invoice date for historical third-party vendors. 60 days from the invoice date for new vendor creations.
45days end of the month for intercompany transactions.
Any changes – answer no - Dispute resolution process
In case of any discrepancy between goods received and invoice receipt - person who made an order is responsible for contacting the vendor and understand the difference
There is a generic email address and direct phone number available for all vendors where all payment related questions can be routed
Terms and conditions are attached to the copy of the Purchase Order that is sent to vendors
Earlier payment reports (11 shown)
- 28.0 average days to pay26.0% outside terms
- 34.0 average days to pay23.0% outside terms
- 35.0 average days to pay23.0% outside terms
- 32.0 average days to pay21.0% outside terms
- 32.0 average days to pay22.0% outside terms
- 30.0 average days to pay29.0% outside terms
- 30.0 average days to pay28.0% outside terms
- 32.0 average days to pay22.0% outside terms
- 29.0 average days to pay19.0% outside terms
- 28.0 average days to pay23.0% outside terms
- 30.0 average days to pay16.0% outside terms
This is a company-submitted statutory disclosure, not a credit rating. BritDB preserves the reporting period and links the report only through the Companies House number supplied by the official service. Percentages describe payments made during that period and may change in later reports.
05 Global legal identity
Legal Entity Identifier
IPSEN BIOPHARM LIMITED
LEI 549300JVUFJ49KCG7N14 · jurisdiction GB
- Legal form
- 8888
- Entity category
- GENERAL
- Entity created
- Not supplied
- Initial LEI registration
- 16 January 2014
- LEI last updated
- 31 July 2023
- Next renewal
- 5 January 2017
- Managing LOU
- 213800WAVVOPS85N2205
- Legal address
- ASH ROAD, WREXHAM INDUSTRIAL ESTATE, WREXHAM, GB-LAN, LL13 9UF, GB
- Headquarters address
- ASH ROAD, WREXHAM INDUSTRIAL ESTATE, WREXHAM, GB-LAN, LL13 9UF, GB
LEI data provides global legal identity and source-reported relationships, not a credit or regulatory approval. BritDB links Level 1 identities only through GLEIF’s Companies House registration-authority identifier and exact company number; Level 2 parent and fund relationships and reporting exceptions are reproduced as supplied by GLEIF.
06 Supply-chain transparency
Modern slavery statement
- Organisation
- IPSEN BIOPHARM LIMITED
- Group submission
- No
- Statement period
- 19 June 2019 – 28 November 2020
- Approved
- 9 April 2021
- Sectors
- Healthcare and pharmaceuticals
Organisation structure
Covered in the statement
Policies
Covered in the statement
Risk assessment
Covered in the statement
Due diligence
Covered in the statement
Training
Covered in the statement
Goals and KPIs
Covered in the statement
Full statement information supplied to the registry
- Reported turnover band
- £100 million to £500 million
- Years producing statements
- 1 to 5 years
- ILO indicators included
- Not answered
- Registry record updated
- 29 April 2021
A registry entry records what the organisation declared in its statement. It is not an independent audit. Group statements can cover several companies; BritDB preserves each exact source-supplied company-number link and excludes approver names and email addresses.
07 Data protection
ICO fee-payer registration
Ipsen Biopharm Limited
Registration Z5934090
- Registered from
- 25 October 2001
- Current end date
- 24 October 2026
This is a candidate association, not an official Companies House link. The ICO file supplies no company number. The organisation name and postcode uniquely matched this company in the current snapshot. BritDB excludes all DPO contact fields and does not publish unmatched personal entries.
TM UK trade marks
Exact owner-name matches
homezone
Owner Ipsen Biopharm Limited · classes 5,10,35,44
- Filed / designated
- 30 March 2017
- Valid until / renewal due
- 30 March 2027
ALLUZIENCE
Owner Ipsen Biopharm Limited · classes 3,5,10
- Filed / designated
- 1 September 2016
- Valid until / renewal due
- 1 September 2026
AQQINTELLE
Owner Ipsen Biopharm Limited · classes 3,5,10
- Filed / designated
- 1 September 2016
- Valid until / renewal due
- 1 September 2026
AQQISTIA
Owner Ipsen Biopharm Limited · classes 3,5,10
- Filed / designated
- 1 September 2016
- Valid until / renewal due
- 1 September 2026
AZZELFIA
Owner Ipsen Biopharm Limited · classes 3,5,10
- Filed / designated
- 1 September 2016
- Valid until / renewal due
- 1 September 2026
AZZINTESSE
Owner Ipsen Biopharm Limited · classes 3,5,10
- Filed / designated
- 1 September 2016
- Valid until / renewal due
- 1 September 2026
EAZZESS
Owner Ipsen Biopharm Limited · classes 3,5,10
- Filed / designated
- 1 September 2016
- Valid until / renewal due
- 1 September 2026
EVERDIA
Owner Ipsen Biopharm Limited · classes 3,5,10
- Filed / designated
- 1 September 2016
- Valid until / renewal due
- 1 September 2026
EVERNELLE
Owner Ipsen Biopharm Limited · classes 3,5,10
- Filed / designated
- 1 September 2016
- Valid until / renewal due
- 1 September 2026
EVERNESSE
Owner Ipsen Biopharm Limited · classes 3,5,10
- Filed / designated
- 1 September 2016
- Valid until / renewal due
- 1 September 2026
LIQQALIS
Owner Ipsen Biopharm Limited · classes 3,5,10
- Filed / designated
- 1 September 2016
- Valid until / renewal due
- 1 September 2026
ZENZIENCE
Owner Ipsen Biopharm Limited · classes 3,5,10
- Filed / designated
- 1 September 2016
- Valid until / renewal due
- 1 September 2026
ZOLUTESSE
Owner Ipsen Biopharm Limited · classes 3,5,10
- Filed / designated
- 1 September 2016
- Valid until / renewal due
- 1 September 2026
Figurative mark
Owner Ipsen Biopharm Limited · classes 3,5,41
- Filed / designated
- 2 December 2011
- Valid until / renewal due
- 2 December 2021
Figurative mark
Owner Ipsen Biopharm Limited · classes 3,5,41
- Filed / designated
- 14 November 2011
- Valid until / renewal due
- 14 November 2021
REVEAL THE CONFIDENCE DYSPORT
Owner Ipsen Biopharm Limited · classes 3,5,41
- Filed / designated
- 6 October 2011
- Valid until / renewal due
- 6 October 2021
Dysport
Owner Ipsen Biopharm Limited · classes 5
- Filed / designated
- 2 March 2011
- Valid until / renewal due
- 2 March 2021
Dyssupport
Owner Ipsen Biopharm Limited · classes 5,9,41,44
- Filed / designated
- 27 September 2010
- Valid until / renewal due
- 27 September 2020
SPEYWOOD
Owner Ipsen Biopharm Limited · classes 3,5,10,42,44
- Filed / designated
- 12 March 2008
- Valid until / renewal due
- 12 March 2028
SPEYWOOD UNITS
Owner Ipsen Biopharm Limited · classes 3,5,10,42,44
- Filed / designated
- 30 November 2007
- Valid until / renewal due
- 30 November 2027
Dysport BOTULINUM TOXIN TYPE A
Owner Ipsen Biopharm Limited · classes 3,5
- Filed / designated
- 11 September 2006
- Valid until / renewal due
- 11 September 2026
Dysport
Owner Ipsen Biopharm Limited · classes 3,5
- Filed / designated
- 24 March 2006
- Valid until / renewal due
- 24 March 2026
Dysport CLOSTRIDIUM BOTULINUM TYPE A TOXIN-HAEMAGGLUTININ COMPLEX
Owner Ipsen Biopharm Limited · classes 3,5
- Filed / designated
- 24 March 2006
- Valid until / renewal due
- 24 March 2026
HomeZone
Owner Ipsen Biopharm Limited · classes 5,10,35,44
- Filed / designated
- 10 February 2004
- Valid until / renewal due
- 10 February 2024
HomeZone Kids
Owner Ipsen Biopharm Limited · classes 5,10,35,44
- Filed / designated
- 10 February 2004
- Valid until / renewal due
- 10 February 2024
HOMEZONE
Owner Ipsen Biopharm Limited · classes 5,10,35,44
- Filed / designated
- 5 February 2004
- Valid until / renewal due
- 5 February 2024
PORCINATE
Owner Ipsen Biopharm Limited · classes 5
- Filed / designated
- 10 December 1999
- Valid until / renewal due
- 10 December 2019
DYSLOR
Owner Ipsen Biopharm Limited · classes 5
- Filed / designated
- 26 January 1999
- Valid until / renewal due
- 26 January 2019
Figurative mark
Owner Ipsen Biopharm Limited · classes 5
- Filed / designated
- 19 January 1999
- Valid until / renewal due
- 19 January 2019
XHATE: C
Owner Ipsen Biopharm Limited · classes 5
- Filed / designated
- 19 January 1999
- Valid until / renewal due
- 19 January 2019
This is an exact normalised company-name match, not a registrar-confirmed ownership link. Another legal entity can have the same or a very similar name. UKIPO data is a historical 2018 snapshot; verify the owner and current status before relying on it.
08 Ownership and control
People with significant control
Ipsen Developments Limited
- Owns 75% or more of shares
- Controls 75% or more of voting rights
- Can appoint or remove directors
- Country registered
- England And Wales
- Legal authority
- Companies Act 2006
- Legal form
- Limited By Shares
- Place registered
- Companies House
- Registration number
- 03200696
- Notified
- 6 April 2016
PSC records are company-filed public-register information. When the exact same displayed individual name occurs at multiple companies, BritDB offers a non-indexed cross-reference page. It is a name match only, not proof that the records describe the same person. Service addresses and partial dates of birth are deliberately omitted.
09 Charity register
Charity Commission links
No exact company-number link in this snapshot
The Charity Commission extract did not explicitly associate this Companies House number with a charity. BritDB does not use a name-only match to fill the gap.
This company-level check covers the Charity Commission for England and Wales. Links are accepted only when the official extract supplies this exact company registration number. Scottish charities now have separate OSCR profiles, but OSCR’s bulk fields do not provide a Companies House number, so BritDB does not infer a company link.
10 Northern Ireland charity register
CCNI exact company links
No unambiguous company-number link found
The CCNI source number did not resolve uniquely to this Companies House record. BritDB did not use a name or address match.
CCNI publishes company numbers without a jurisdiction prefix. BritDB links only when the plausible padded UK and NI candidates resolve to exactly one Companies House company.
11 Sanctions screening
UK Sanctions List
No exact business-registration-number link found
The imported UK Sanctions List did not supply this Companies House number as a UK-linked business identifier. BritDB did not attempt a name-only match.
No exact link is not sanctions clearance. UK restrictions can apply through ownership or control even where an entity is not separately named. Always use the current official list and obtain appropriate advice for a legally significant decision.
12 Public procurement
Find a Tender links
No exact GB-COH link in this snapshot
Find a Tender did not explicitly identify this Companies House number in a procurement party. BritDB did not attempt a name-only match.
These links use only the GB-COH identifier supplied in the procurement record. A company may have other public-sector work that is absent, older, below publication thresholds or published without a Companies House identifier.
13 Environmental register
Environment Agency waste registrations
No exact company-number registration linked
The licensed Environment Agency subset did not contain this exact Companies House number. BritDB did not attempt a name-only match.
This is a privacy-reduced, exact-company subset. The full official register also includes sole traders and applicants without a matching Companies House number. Check the current Environment Agency register before relying on registration status.
14 Nature of business
Standard Industrial Classification
15 Connected public record
Checks beyond the company register
Charity Commission
0 exact company-number links.
Northern Ireland charities
0 unambiguous company-number links.
Public contracts
0 procurement processes linked by exact GB-COH identifier.
Waste register
0 exact company-number registrations.
Corporate notices
The Gazette is not yet connected.
UK Sanctions List
No exact business-registration-number link in this report.
A checked source with no exact link is not a clean bill of health. Unchecked sources remain unknown, while sanctions may also apply through ownership or control of a listed person or entity.
16 Record timeline
Dates in the bulk record
- Confirmation statement
Latest confirmation statement made up to this date
- Accounts
Latest accounts made up to this date
- Incorporation
Company incorporated
17 Provenance
Sources for this profile
Identity, address, status, dates, SIC, previous names and mortgage totals.
Annual employer reports linked by the exact source-supplied Companies House number.
Statutory supplier-payment reports linked by the exact source-supplied Companies House number.
Global legal identities linked through Companies House registration authority RA000585.
Annual statement summaries linked by exact source company number.
Privacy-reduced candidate associations based on a unique exact name-and-postcode match.
Current and ceased significant-control records joined by exact company number.
Daily England and Wales extract matched only by the official company registration number.
Daily CCNI export with company links only where the source number resolves unambiguously.
Complete FCDO list checked by exact UK-linked business registration number.
Procurement parties checked only through exact GB-COH identifiers.
Licensed subset linked only by exact Companies House number.
Financial regulation and licences.
Companies House, Charity Commission, OSCR and UK Sanctions List information is public-register data. BritDB reproduces and organises it with source-specific limits; official external links are kept on the dedicated source pages.